Pharming Group Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Pharming Group stock have an average target of 30, with a low estimate of 14 and a high estimate of 39. The average target predicts an increase of 244.83% from the current stock price of 8.70.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$30	$37	$39
Change	+60.92%	+244.83%	+325.29%	+348.28%

Analyst Ratings

The average analyst rating for Pharming Group stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	2	2	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+325.29%	Mar 21, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+325.29%	Mar 20, 2025
Michael Carrier Oppenheimer	Oppenheimer	Buy Maintains $30 → $39	Buy	Maintains	$30 → $39	+348.28%	Mar 14, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+325.29%	Mar 14, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+325.29%	Dec 17, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

321.74M

from 297.20M

8.26%

from 297.20M

Revenue Next Year

353.03M

from 321.74M

9.73%

from 321.74M

EPS This Year

-0.01

from -0.02

EPS Next Year

0.00

from -0.01

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	212.17M	198.87M	205.62M	245.32M	297.20M	321.74M	353.03M	436.07M
Revenue Growth	12.03%	-6.27%	3.40%	19.30%	21.15%	8.26%	9.73%	23.52%
EPS	0.05	0.02	0.02	-0.02	-0.02	-0.01	0.00	0.06
EPS Growth	-9.84%	-58.18%	-17.39%	-	-	-	-	1,770.77%
Forward PE	-	-	-	-	-	-	2,598.95	138.92
No. Analysts	-	-	-	-	-	8	8	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	358.5M	434.0M	569.7M
Avg	321.7M	353.0M	436.1M
Low	284.3M	273.7M	323.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	20.6%	34.9%	61.4%
Avg	8.3%	9.7%	23.5%
Low	-4.3%	-14.9%	-8.4%

EPS Forecast

EPS	2025	2026	2027
High	0.04	0.11	0.08
Avg	-0.01	0.00	0.06
Low	-0.06	-0.06	0.04

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	2,321.5%
Avg	-	-	1,770.8%
Low	-	-	1,199.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.